Form 4 for OGN Organon & Co.
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0001628280-26-014222 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-03 | 2026-02-27 | OGN | Weaver Kirke | Gen. Counsel, Corp. Secy | F - Tax | $7.18 | -8,578 | 73.9K | -10% | -$61.6K |
| M | 2026-03-03 | 2026-02-27 | OGN | Weaver Kirke | Gen. Counsel, Corp. Secy | A - Grant | $0.00 | +28.1K | 73.8K | +62% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-27 | F | D | 6,815 | $7.17 | 67,599 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-27 | A | A | 21,925 | $0.00 | 74,414 | D | — | — | (F1) Represents shares of Organon & Co. common stock ("Common Stock") for performance share units ("PSUs") granted to the reporting person on August 11, 2023 under the Organon & Co. 2021 Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors. |
| 3 | Common | Common Stock | 2026-02-27 | A | A | 6,186 | $0.00 | 73,785 | D | — | — | (F2) Represents the shares of Common Stock released to cover the dividend equivalents earned on the PSUs released above. |
| 4 | Common | Common Stock | 2026-02-27 | F | D | 1,763 | $7.23 | 73,854.16 | D | — | — | (F3) Includes the addition of 1,832.163 shares of Common Stock acquired from dividend equivalents not previously required to be reported. |